Factors related to lithium blood concentrations in Chinese Han patients with bipolar disorder

References

• Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387(10027):1561–1572. doi:10.1016/S0140-6736(15)00241-X26388529
   PubMed Web of Science ®Google Scholar
• Hou L, Heilbronner U, Degenhardt F, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016;387(10023):1085–1093. doi:10.1016/S0140-6736(16)00143-426806518
   PubMed Web of Science ®Google Scholar
• Pisanu C, Melis C, Squassina A. Lithium pharmacogenetics: where do we stand? Drug Develop Res. 2016;77(7):368–373. doi:10.1002/ddr.21341
   Web of Science ®Google Scholar
• Yan Z, Yang X, Wang L, Zhao Y, Yu L. Social change and birth cohort increase in loneliness among Chinese older adults: a cross-temporal meta-analysis, 1995–2011. Int Psychogeriatr. 2014;26(11):1773–1781. doi:10.1017/S104161021400092124887197
   PubMed Web of Science ®Google Scholar
• Zhang L, Cao X-L, Wang S-B, et al. The prevalence of bipolar disorder in China: a meta-analysis. J Affect Disord. 2017;207:413–421. doi:10.1016/j.jad.2016.08.06227771597
   PubMed Web of Science ®Google Scholar
• Methaneethorn J. Population pharmacokinetic analyses of lithium: a systematic review. Eur J Drug Metab Pharmacokinet. 2018;43(1):25–34. doi:10.1007/s13318-017-0421-228555320
   PubMed Web of Science ®Google Scholar
• Eldesoky ES, Kumar V, Alorainy MS, Hamdi MM, Derendorf H. Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach. Int J Clin Pharm Th. 2008;46(12):617–626.
   Web of Science ®Google Scholar
• Finley PR. Drug interactions with lithium: an update. Clin Pharmacokinet. 2016;55(8):925–941.26936045
   PubMed Web of Science ®Google Scholar
• Perez-Castello I, Mangas-Sanjuan V, Gonzalez-Garcia I, et al. Population pharmacokinetic model of lithium and drug compliance assessment. Eur Neuropsychopharmacol. 2016;26(12):1868–1876.27865605
   PubMed Web of Science ®Google Scholar
• Rej S, Beaulieu S, Segal M, et al. Lithium dosing and serum concentrations across the age spectrum: from early adulthood to the tenth decade of life. Drugs Aging. 2014;31(12):911–916. doi:10.1007/s40266-014-0221-125331906
   PubMed Web of Science ®Google Scholar
• Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiat Res. 2014;218(1–2):61–68. doi:10.1016/j.psychres.2014.04.005
   PubMed Web of Science ®Google Scholar
• Sussulini A, Dihazi H, Banzato CE, et al. Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder. Proteomics. 2011;11(2):261–269. doi:10.1002/pmic.20100037121204253
   PubMed Web of Science ®Google Scholar
• Ahmad M, Elnakady Y, Farooq M, Wadaan M. Lithium induced toxicity in rats: blood serum chemistry, antioxidative enzymes in red blood cells and histopathological studies. Biol Pharm Bull. 2011;34(2):272–277.21415540
   PubMed Web of Science ®Google Scholar
• Shen HC, Li JY, Lo YK. Lithium intoxication-induced acute parkinsonism complicated with hyperparathyroidism and nephrogenic diabetes insipidus: report of a case. Acta Neurol Taiwan. 2007;16(4):231–233.18220017
   PubMedGoogle Scholar
• Grunfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol. 2009;5(5):270–276. doi:10.1038/nrneph.2009.4319384328
   PubMed Web of Science ®Google Scholar
• Matsuura H, Kimoto S, Harada I, Naemura S, Yamamuro K, Kishimoto T. Lithium carbonate as a treatment for paliperidone extended-release-induced leukopenia and neutropenia in a patient with schizoaffective disorder; a case report. BMC Psychiatry. 2016;16:161. doi:10.1186/s12888-016-0874-x27229149
   PubMed Web of Science ®Google Scholar
• Sporn A, Gogtay N, Ortiz-Aguayo R, et al. Clozapine-induced neutropenia in children: management with lithium carbonate. J Child Adol Psychop. 2003;13(3):401–404. doi:10.1089/104454603322572697
   Web of Science ®Google Scholar
• Yu W, Sun X, Li Y, Li M, Wang K, Li H. Population pharmacokinetics of lithium carbonate in young male healthy Chinese volunteers. Pharmacopsychiatry. 2016;49(5):177–181. doi:10.1055/s-0042-10332927124003
   PubMed Web of Science ®Google Scholar
• Sani G, Perugi G, Tondo L. Treatment of bipolar disorder in a lifetime perspective: is lithium still the best choice? Clin Drug Invest. 2017;37(3):713–727. doi:10.1007/s40261-017-0531-2
   Web of Science ®Google Scholar
• Pottel H, Delanaye P, Schaeffner E, et al. Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant. 2017;32(3):497–507. doi:10.1093/ndt/gfw42528089986
   PubMed Web of Science ®Google Scholar
• Castro VM, Roberson AM, McCoy TH, et al. Stratifying risk for renal insufficiency among lithium-treated patients: an electronic health record study. Neuropsychopharmacology. 2016;41(4):1138–1143. doi:10.1038/npp.2015.25426294109
   PubMed Web of Science ®Google Scholar
• Paul R, Minay J, Cardwell C, Fogarty D, Kelly C. Meta-analysis of the effects of lithium usage on serum creatinine levels. J Psychopharmacol. 2010;24(10):1425–1431. doi:10.1177/026988110910493019395432
   PubMed Web of Science ®Google Scholar
• Amitai M, Zivony A, Kronenberg S, et al. Short-term effects of lithium on white blood cell counts and on levels of serum thyroid-stimulating hormone and creatinine in adolescent inpatients: a retrospective naturalistic study. J Child Adol Psychop. 2014;24(9):494–500. doi:10.1089/cap.2013.0046
   PubMed Web of Science ®Google Scholar
• Bozikas V, Xafenias T, Andreou C, et al. Chronic renal insufficiency after long term lithium treatment. Psychiatriki. 2007;18(2):168–172.22466524
   PubMedGoogle Scholar
• Tondo L, Abramowicz M, Alda M, et al. Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters. Int J Bipolar Disord. 2017;5(1):27. doi:10.1186/s40345-017-0096-228480485
   PubMed Web of Science ®Google Scholar
• Dean B, Digney A, Sundram S, Thomas E, Scarr E. Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder. Psychiat Res. 2008;158(1):75–78. doi:10.1016/j.psychres.2007.05.008
   Web of Science ®Google Scholar
• Viktorinova A, Jurkovicova I, Fabryova L, et al. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes. Diabetes Res Clin Pr. 2018;140:174–182. doi:10.1016/j.diabres.2018.03.055
   Web of Science ®Google Scholar
• Banerjee U, Dasgupta A, Rout JK, Singh OP. Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012;37(1):56–61. doi:10.1016/j.pnpbp.2011.12.00622230647
   PubMed Web of Science ®Google Scholar
• Cui X, Xie Z. Protein interaction and Na/K-ATPase-mediated signal transduction. Molecules. 2017;22(6):pii: E990.
   Web of Science ®Google Scholar
• Vosahlikova M, Ujcikova H, Chernyavskiy O, et al. Effect of therapeutic concentration of lithium on live HEK293 cells; increase of Na(+)/K(+)-ATPase, change of overall protein composition and alteration of surface layer of plasma membrane. Biochim Biophys Acta Gen Subj. 2017;1861(5 Pt A):1099–1112. doi:10.1016/j.bbagen.2017.02.01128215700
   PubMed Web of Science ®Google Scholar
• Gong R, Wang P, Dworkin L. What we need to know about the effect of lithium on the kidney. Am J Physiol Renal Physiol. 2016;311(6):F1168–F1171. doi:10.1152/ajprenal.00145.201627122541
   PubMed Web of Science ®Google Scholar
• Lapierre G, Stewart RB. Lithium carbonate and leukocytosis. Am J Hosp Pharm. 1980;37(11):1525–1528.7211857
   PubMedGoogle Scholar
• Carmen J, Okafor K, Ike E. The effects of lithium therapy on leukocytes: a 1-year follow-up study. J Natl Med Assoc. 1993;85(4):301–303.8478973
   PubMed Web of Science ®Google Scholar
• Dumas R, Bardin P, Vedie C. Long-term treatment of clozapine-induced leukopenia with lithium: fast-onset agranulocytosis following lithium discontinuation. Prim Care Companion CNS Disord. 2016;18(1). doi:10.4088/PCC.15l01841
   Google Scholar
• Suraweera C, Hanwella R, de Silva V. Use of lithium in clozapine-induced neutropenia: a case report. BMC Res Notes. 2014;7:635. doi:10.1186/1756-0500-7-63525214394
   PubMedGoogle Scholar
• Ghaznavi S, Nakic M, Rao P, et al. Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia. Am J Psychiatry. 2008;165(7):813–818. doi:10.1176/appi.ajp.2008.0711182318593787
   PubMed Web of Science ®Google Scholar
• Phiel CJ, Klein PS. Molecular targets of lithium action. Annu Rev Pharmacol Toxicol. 2001;41:789–813. doi:10.1146/annurev.pharmtox.41.1.78911264477
   PubMed Web of Science ®Google Scholar
• Sethy RR, Sinha VK. Effect of lithium on thyroid function in adolescents with mood disorder. Asian J Psychiatr. 2016;24:41–45. doi:10.1016/j.ajp.2016.08.00427931904
   PubMed Web of Science ®Google Scholar